Strengthening Bio-Techne’s leadership in the spatial genomics market with significant expansion of the ACD RNAscope HiPlex platform capabilities MINNEAPOLIS — Bio-Techne Corporation (NASDAQ: TECH) today announced the expansion of the Advanced Cell Diagnostics (ACD), a Bio-Techne brand, RNAscope in situ hybridization technology portfolio with the release of new RNAscope HiPlex V2 assay for formalin-fixed paraffin-embedded (FFPE) […]
Agreement to Cross License Single Cell Technologies Ends all Ongoing Legal Disputes PLEASANTON, Calif. — 10x Genomics, Inc. (Nasdaq: TXG) today announced that it has entered into a global settlement and cross-license agreement with Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb). The agreement resolves all outstanding litigation and other proceedings between the two companies across […]
Nobel prize winning CRISPR technology to be applied in development of genetically engineered animal models Dublin, Ireland & Shizuoka, Japan: ERS Genomics Limited, which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property co-owned by Dr. Emmanuelle Charpentier, and Japan SLC, Inc., a biotechnology company providing animal models to the research community, today […]
Scintica is excited to announce its new and extended distribution agreement with Baker Ruskinn, global leader and supplier of anaerobic and modified atmosphere solutions for microbiology and tissue/cell culture applications. The Baker Company, global leader in containment technology, owner of Baker Ruskinn, itself a global leader in anaerobic and precision low-oxygen culture solutions for microbiology […]
SOUTH SAN FRANCISCO, Calif. & KAWASAKI, Japan — Twist Bioscience Corporation (Nasdaq: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, and MOLCURE Inc., today announced they generated potent, binding antibodies to an undisclosed oncology target for Twist’s internal pipeline of antibody candidates. The collaborative research […]
Vizgen, Spatial Genomics Innovator, Expands Leadership Team Leader in spatially resolved, single-cell transcriptomics appoints Bob Koshgarian as VP of Operations, advancing company towards MERSCOPE™ commercialization CAMBRIDGE, Mass. —Vizgen, the life science company dedicated to improving human health by visualizing single-cell spatial genomics information, has announced that Bob Koshgarian has joined the leadership team as Vice President of […]
Transformative deal significantly scales leading position in life science to accelerate legendary discoveries in precision medicine Leader in antibody development with highly complementary, innovative portfolio in emerging, high-growth areas of biologics, cell and gene therapy, proteogenomics, and recombinant proteins Commercial synergy opportunity to accelerate life science growth with potential benefits for diagnostics franchise Annual BioLegend revenues of […]
SOUTH SAN FRANCISCO, Calif.— Twist Bioscience Corporation (Nasdaq: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that it has started shipping its synthetic RNA reference controls for the SARS-CoV-2 Delta (B.1.617.2) and B.1.617.3 variants first identified in India and spreading rapidly worldwide. “Just […]
FREMONT, Calif. — Cytek Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), a leading cell analysis solutions company, announced today the pricing of its initial public offering of an aggregate of 16,749,330 shares of its common stock at a price to the public of $17.00 per share. The gross proceeds to Cytek from the offering, […]
AMSTERDAM — LUMICKS, a leading next generation life science tools company renowned for its innovative platforms for Dynamic Single-Molecule and Cell Avidity analysis, has installed its ground-breaking z-Movi® Cell Avidity Analyzer at INmune Bio (NASDAQ: INMB). INmune Bio is a clinical stage biotechnology company developing new therapies that modulate the innate immune system to treat cancer […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
